Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > No volume and no liquidity

<< Previous

Bullboard Posts

Next >>

Comment by Gorf79on Aug 29, 2022 9:41am

212 Views

Post# 34926341

RE:RE:RE:RE:RE:No volume and no liquidity

The next negative?

It could be that Infomed production, while fully geared up for Dialco's US market initiatives, can't meet the unexpected demand of the initial ARC and Veterans Affairs orders. Those now forgotten and washed through deals did look rather significant when announced. Worthless now though...

If they leave that other shoe ready to drop long enough, and make no effort to broaden market interest, it will soon be 40 cent option season all over again. Imagine that!

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China